The drug store chain-slash-health care juggernaut leapt three spots on this year's Fortune 500—and got a $62 billion revenue boost—due to its $69 billion acquisition of Aetna, the insurance giant, in 2018. Though investors haven’t entirely sweetened on the deal, CEO Larry Merlo pronounced the integration of the two companies “successful” in February; former Aetna CEO Mark Bertolini, meanwhile, resigned from the CVS board and said the integration was “far from over.” As a pharmacy retailer on the pandemic’s frontlines, CVS’s sales were brisk in the first quarter, but Merlo has warned about the “uncertainties” that surround the long-term performance of the company’s multifaceted business in a time of COVID-19.
Lists ranking CVS Health
RANK38
World’s Most Admired Companies - 2020For an astounding 13th straight year, Apple claims...view in list
Latest news for CVS Health
- FinanceShareholders dunked on CEO pay at CVS and Intel. Stock performance may be nextMay 21, 2020 5:58 PM UTC
- HealthWalmart, Target, CVS, and Walgreens will loan space for coronavirus test centersMarch 13, 2020 10:27 PM UTC
- NewslettersCVS will waive out-of-pocket costs related to coronavirus testing and telemedicine visitsMarch 6, 2020 3:56 PM UTC
- NewslettersCVS CEO on What’s Happened After Its Aetna Merger—and What Comes NextDecember 6, 2019 9:41 PM UTC